Harbin Pharmaceutical Group Co (SHSE:600664) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 13, 2024)

View and export this data going back to 1993. Start your Free Trial

What is Harbin Pharmaceutical Group Co EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.

Harbin Pharmaceutical Group Co (SHSE:600664) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Harbin Pharmaceutical Group Co EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Harbin Pharmaceutical Group Co's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Harbin Pharmaceutical Group Co (SHSE:600664) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Harbin Pharmaceutical Group Co Ltd (SHSE:600664) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Traded in Other Exchanges

N/A

Address

Xi'an Street West, People 's Development Zone Baoan Road South, Heilongjiang Province, Harbin, CHN, 150018

Website

http://www.hayao.com

Harbin Pharmaceutical Group Co Ltd is engaged in manufacturing, trading and research and development of pharmaceuticals. The company is organized into seven business segments - Antibiotics, Small-Molecular drug preparations, OTC and healthcare products, Modern Chinese medicines, Biopharmaceuticals, Animal vaccines, and medicine circulations. The company sells its products across China and fifty other countries. Some of its brands are - Hayao, Sanjing, Gaizhonggai, Hutong, and Shiyitang.

Executives

Lin Guo Ren	senior management
Wang Hai Sheng	senior management
Liu Bo	senior management
Meng Xiao Dong	senior management
Xu Hai Ying	Directors, senior managers
Liang Chen	senior management
Wang Peng Hao	senior management
Xiao Qiang	senior management
Wei Shuang Ying	senior management
Zhou Xing	senior management
Bian Ke	Supervisors
Sha Mei	senior management
Jian Shi Hui Zhu Xi	Supervisors
Wang Zhi Fu	Supervisors
Jiang Lu	Director

Harbin Pharmaceutical Group Co (SHSE:600664) Headlines

No Headlines